TIMP3 and prostate cancer: Decreased levels of TIMP‐3 have been shown in various human malignancies including breast cancer, prostate cancer, gastric cancer, esophageal squamous cell carcinoma, endometrial cancer, and cholangiocarcinomas.12, 13, 14, 15, 16